Clinical trials: Pancreatic Cystic Lesion, open to volunteers
Pancreatic Cystic Lesion (PCL)
An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography
The aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopic ultrasound system-pancreatic cystic lesions） for detecting and multimodal, multi-class diagnosing…
- Trial name
- NCT07543263
- Testing
- iEUS-PCL(intelligent endoscopic ultrasound system- pancreatic cystic lesion)
- Where
- China
- Volunteers
- 176 people
- Sponsor
- Qilu Hospital of Shandong University
Pancreatic Cystic Lesions
A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions
The purpose of this research is to learn if the PanCystPro assay can help doctors in making decisions about treatment and monitoring of pancreatic cysts.
- Trial name
- PanAMP (NCT06894329)
- Where
- 3 sites in United States
- Volunteers
- 50 people
- Sponsor
- Amplified Sciences Inc
Pancreatic Cystic Lesion, Mucinous Cystadenoma of Pancreas
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
The primary objective is to construct a multimodal AI model (Cyst-AI) based on EUS images and clinical data such as imaging features(CT or MRI) and laboratory tests to assist endoscopists in the diagnosis of pancreatic cystic…
- Conditions
- Pancreatic Cystic Lesion, Mucinous Cystadenoma of Pancreas, Intraductal Papillary Mucinous Neoplasm of Pancreas, Pseudocyst Pancreas
- Trial name
- NCT07463872
- Testing
- Cyst-AI model
- Where
- 2 sites in China
- Volunteers
- 500 people
- Sponsor
- Huazhong University of Science and Technology
Pancreatic Cancer, Diagnose Disease
AI-Powered Precision Decision-Making for Pancreatic Diseases
This multicenter clinical trial evaluates an artificial intelligence (AI) system designed to assist in the diagnosis and management of pancreatic diseases.
- Conditions
- Pancreatic Cancer, Diagnose Disease, IPMN, Pancreatic, Pancreatic Cystic Lesions
- Trial name
- NCT07439757
- Testing
- Diagnosis by Artificial Intelligence model
- Where
- China
- Volunteers
- 2,000 people
- Sponsor
- Changhai Hospital
Pancreatic Cystic Lesions
A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions
The purpose To determine the diagnostic potential of various biological markers in blood and cyst fluid aspirates from patients with Pancreatic Cystic Lesions (PCLs).
- Trial name
- NCT02647177
- Testing
- Pancreatic Cyst Aspiration
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- The University of Texas Health Science Center, Houston
Pancreatic Cancer, Pancreatic Cystic Lesions
Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence
This international, multicenter retrospective study aims to develop a deep learning (DL)-based predictive model to identify malignant transformation in pancreatic cystic lesions, improving upon current clinical guidelines.
- Trial name
- NCT06954753
- Testing
- Pancreatic surgery
- Volunteers
- 250 people
- Sponsor
- Centre Hospitalier Universitaire de Nice
Pancreatic Cystic Lesion
Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions
Large prospective comparative observational study in numerous reference centers in France, comparing infectious complications in patients admitted for pancreatic cystic lesions (PCL) aspiration performed with or without…
- Trial name
- PrePaCyst (NCT06535490)
- Testing
- EUS-FNA, ATBp
- Where
- France
- Volunteers
- 1,702 people
- Sponsor
- Société Française d'Endoscopie Digestive